Pre-treatment factors associated with detecting additional brain metastases at stereotactic radiosurgery.

J Neurooncol 2016 06 10;128(2):251-7. Epub 2016 Mar 10.

Department of Radiation Oncology, Inova Dwight and Martha Schar Cancer Institute, 3300 Gallows Road, Falls Church, VA, 22042, USA.

The number of brain metastases identified on diagnostic magnetic resonance imaging (MRI) is a key factor in consideration of stereotactic radiosurgery (SRS). However, additional lesions are often detected on high-resolution SRS-planning MRI. We investigated pre-treatment clinical characteristics that are associated with finding additional metastases at SRS. Patients treated with SRS for brain metastases between the years of 2009-2014 comprised the study cohort. All patients underwent frame-fixed, 1 mm thick MRI on the day of SRS. Patient, tumor, and treatment characteristics were analyzed for an association with increase in number of metastases identified on SRS-planning MRI. 289 consecutive SRS cases were analyzed. 725 metastases were identified on pre-treatment MRI and 1062 metastases were identified on SRS-planning MRI. An increase in the number of metastases occurred in 34 % of the cases. On univariate analysis, more than four metastases and the diameter of the largest lesion were significantly associated with an increase in number of metastases on SRS-planning MRI. When stratified by the diameter of the largest lesion into <2, 2-3, or ≥3 cm, additional metastases were identified in 37, 29, and 18 %, respectively. While this increase in the number of metastases is largely due to the difference in imaging technique, the number and size of the metastases were also associated with finding additional lesions. These clinical factors may be considered when determining treatment options for brain metastases.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-016-2103-3DOI Listing
June 2016
8 Reads

Publication Analysis

Top Keywords

srs-planning mri
16
metastases identified
16
increase number
12
number metastases
12
brain metastases
12
metastases
10
largest lesion
8
diameter largest
8
stereotactic radiosurgery
8
identified srs-planning
8
mri
7
srs
5
occurred 34 %
4
associated finding
4
study cohort
4
comprised study
4
cohort patients
4
underwent frame-fixed
4
metastases occurred
4
patients underwent
4

References

(Supplied by CrossRef)

EB Claus et al.
Nat Rev Clin Oncol 2012

MP Mehta et al.
Int J Radiat Oncol Biol Phys 2005

PW Sperduto et al.
Int J Radiat Oncol Biol Phys 2008

D Mathieu et al.
Neurosurgery 2007

H Kano et al.
Neurosurgery 2011

EL Chang et al.
Lancet Oncol 2009

H Aoyama et al.
JAMA 2006

DW Andrews et al.
Lancet 2004

A Nagai et al.
Neuro-oncology 2010

JA Engh et al.
Stereotact Funct Neurosurg 2007

SJ Henley et al.
MMWR Morb Mortal Wkly Rep 2015

Similar Publications